Skip to content

A Prospective Study to Evaluate the Suture Pattern With the Endomina Suturing Device for Endoscopic Sutured Gastroplasty (ESG).

A Prospective Study to Evaluate the Suture Pattern With the Endomina Suturing Device for Endoscopic Sutured Gastroplasty (ESG).

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03843801
Acronym
Pattern
Enrollment
46
Registered
2019-02-18
Start date
2019-04-02
Completion date
2020-11-26
Last updated
2021-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Endoscopy, Mini invasive

Brief summary

Advances in endoluminal devices are now allowing clinicians the ability to begin exploring bariatric procedures performed via flexible endoscopy. Although these procedures may not be as effective as their surgical counterparts, these less-invasive options may relieve patients of the significant risks associated with surgery (1). Endomina (Endo Tools Therapeutics, Gosselies, Belgium) is CE mark device that may be attached to an endoscope inside the body and allows remote manipulation of the arms of the device during a peroral intervention. It offers the possibilities of making transoral surgical full thickness sutures and may allow performing endoscopic therapeutic interventions, via a transoral route. A first trial including 11 patients assessed feasibility and safety of the technique (2). There were no complications and the short-term results were encouraging. Then a multicentric efficacy study was conducted, including 51 patients (3). The results where EWL of 31% at one year and TBWL of 9% without complications. Finally a randomized controlled study was done including 73 patients in a 2/1 randomized fashion with a crossover at 6 months. Treated group was with the endomina device and controlled group was diet only. The follow-up was the same in each group. Primary endpoint was to reach the ASGE guideline difference between a control group and a treatment group of minimum 15% (4). Technique and suture pattern have evolved since the first study. The aim of this prospective evaluation is to compare different suture patterns and their mechanism of action.

Interventions

DEVICEEndomina

The intervention will be performed under general anesthesia with tracheal intubation. Endomina will be introduced into the stomach over guide wires and then fixed to the endoscope. The procedure will include the placement of transmural anterior-posterior sutures in the stomach in order to achieve a gastric remodelling. Patient will be kept overnight after the procedure.

Sponsors

Erasme University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

1. Age between 18-64 years; 2. BMI between 30 to 40 kg/m² 3. Must be able to comply with all study requirements for the duration of the study as outlined in the protocol. This includes complying with the visit schedule as well as study specific procedures such as: clinical assessment, endoscopy, radiography, gastric emptying scintigraphy, satiety test, as well as laboratory investigations. 4. Must be able to understand and be willing to provide written informed consent. 5. Must have completed the multidisciplinary workup

Exclusion criteria

1. Achalasia and any other esophageal motility disorders 2. Heart diseases: unstable angina, myocardial infarction within the past year, or heart disease classified within the New York Heart Association's Class III or IV functional capacity. 3. Hypertension: uncontrolled hypertension during last 3 month 4. Severe renal, hepatic, pulmonary disease or cancer; 5. GI stenosis or obstruction 6. Pregnancy or breastfeeding or willing to become pregnant within study duration 7. History of gastric surgery (any type) 8. Impending gastric surgery 60 days post intervention 9. History of weight changes (±5% TBWL) within the previous 6 months 10. Placement/removal of an intragastric balloon in less than 6 months 11. Currently participating in other study 12. HP positive

Design outcomes

Primary

MeasureTime frameDescription
Weight lossone year from procedureno difference in weight loss between groups

Secondary

MeasureTime frameDescription
Gastric emptyingone year from procedureEvaluation of the correlation between gastric emptying scintigraphy results and the suture pattern related to motility disruption
Satiety test assessed by the correlation between satiety test and the suture pattern related to volume reductionone year from procedureEvaluation of the correlation between satiety test and the suture pattern related to volume reduction
suturesone year from procedureEvaluation of the correlation between the number of remaining sutures (with gastric remodeling) and weight loss
Excess weight lossone year from procedurePercentage of patients, total and per group, reaching ASGE guidelines of 25% Excess weight loss at 1-year

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026